[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337345-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337345-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-prospective-multi-centered-registry-based-observational-study-for-patients-with-cancer-design-and-rationale-for-korean-medicine-cancer-registry-kmcare-integrative-cancer-therapies-volume-23","A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer - Design and Rationale for Korean Medicine Cancer Registry (KMCARE) - Integrative Cancer Therapies Volume 23","","Cancer remains a leading cause of death, with rising burden on healthcare systems. Existing cancer registries do not capture integrative medical treatments, motivating the Korean Medicine Cancer Registry (KMCARE) to collect conservative care and Korean medicine. A prospective multi-centered registry study will enroll 650 eligible patients receiving Korean medicine within 1 month of diagnosis. Primary outcome is Functional Assessment of Cancer Therapy-General at 3 months; secondary outcomes include MD Anderson Symptom Inventory-Core and Body Constitution Questionnaire at 3 and 6 months, plus safety and survival follow-up.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-prospective-multi-centered-registry-based-observational-study-for-patients-with-cancer-design-and-rationale-for-korean-medicine-cancer-registry-kmcare-integrative-cancer-therapies-volume-23/337345/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-prospective-multi-centered-registry-based-observational-study-for-patients-with-cancer-design-and-rationale-for-korean-medicine-cancer-registry-kmcare-integrative-cancer-therapies-volume-23/337345.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is the KMCARE registry needed for cancer care data?","Question",{"text":63,"@type":64},"Existing cancer registries do not collect integrative medical treatments. KMCARE is established to gather conservative care and Korean medicine data for cancer patients.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the study design and setting for KMCARE?",{"text":68,"@type":64},"KMCARE is a prospective observational study based on a registry conducted in five Korean medical hospitals.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes are measured during follow-up?",{"text":72,"@type":64},"The primary outcome is Functional Assessment of Cancer Therapy-General at 3 months. Secondary outcomes include MD Anderson Symptom Inventory-Core and Body Constitution Questionnaire at 3 and 6 months, with additional safety, survival, and prognostic factor analyses after 6 months.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337345,1790546253,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","A Prospective Multi-Centered RegistryBased Observational Study for Patients With Cancer: Design and Rationale for Korean Medicine Cancer Registry (KMCARE)  \nIntegrative Cancer Therapies Volume 23: 1–7  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/15347354231223496](DOI: 10.1177/15347354231223496)[ ](DOI: 10.1177/15347354231223496)[journals.sagepub.com/home/ict](journals.sagepub.com/home/ict)  \nJee Young Lee, KMD, PhD 1, Hayun Jin, KMD3, Su Bin Park, KMD, MS2, Eun Hye Kim, KMD, MS3, Jee-Hyun Yoon, KMD, PhD2,  \nand Seong Woo Yoon, KMD, PhD2  \nAbstract  \nBackground:Cancer is one of the leading causes of death in most countries with an expected increased burden on healthcare systems. Since integrative medical treatments are not collected within the scope of existing cancer registries, the establishment of the Korean Medicine Cancer Registry (KMCARE), gathering integrative therapies, including conservative care and Korean medicine, is warranted. Methods: A prospective observational study based on the registry will be conducted in 5 Korean medical hospitals. A total of 650 eligible participants undergoing Korean medicine treatments within 1 month of a diagnosis of lung, colorectal, stomach, or breast cancer are anticipated to be enrolled in the registry. Data collected in the KMCARE can be classified into patient information, received treatments, and outcomes. The primary outcome is the Functional Assessment of Cancer Therapy-General Questionnaire score at 3 months. Secondary outcomes include the MD Anderson Symptom Inventory-Core and the Body Constitution Questionnaire at 3 and 6 months. After 6 months of follow-up periods, survival surveillance will be continued for additional 18 months. Descriptive and statistical analysis of primary and secondary outcomes, baseline data, safety, survival, and prognostic factors will be performed. Discussion: This is the first prospective, multi-centered, registry-based observational study of cancer patients in Korean medicine hospitals, which could reveal the current status of cancer patients receiving integrative cancer therapies, and provide better insight into the role of Korean medicine in palliative care for patients with cancer.  \nTrial registration: Clinical Research Information Service (CRIS), KCT0007447.  \nKeywords  \ncancer, Korean medicine, nationwide observational study, Registry, palliative care Submitted June 1, 2023; revised August 11, 2023; accepted December 13, 2023  \nIntroduction  \nCancer is still the first leading cause for death in Republic of Korea and along with the increase in the geriatric population and advances in cancer treatment, its social burden has increased. More than 0.9 million Korean cancer patients or survivors were alive in 2020, and the number of people diagnosed with cancer increased by 18.8% compared to the past 10 years.1 In the past, longer survival and absence of cancerous lesions in the body were considered to be of highest interest. However, with more patients experiencing cancer, interest in palliative care and quality of life inpatients with cancer is inevitably growing.2 In addition,  \n1 CHA Ilsan Medical Center, Goyang, Republic of Korea 2Department of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong, Gangdonggu, Seoul, Republic of Korea 3Department of Clinical Korean Medicine, College of Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea  \nCorresponding Authors:  \nSeong Woo Yoon, Department of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong, Dongnamro 892, Gangdonggu, Seoul 05278, Republic of Korea  \nEmail: [stepano212@hanmail.net](stepano212@hanmail.net)  \nJee-Hyun Yoon, Department of Korean Internal Medicine, Kyung Hee University Hospital at Gangdong, Dongnamro 892, Gangdonggu, Seoul 05278, Republic of Korea.  \nEmail: [suzzaneyoon@gmail.com](suzzaneyoon@gm","cbCaisT7hC5Ayu53","https://ap.wps.com/l/cbCaisT7hC5Ayu53","pdf",501251,"English","# Abstract\n# Introduction\n# Discussion\n# Methods and Outcomes","[{\"question\":\"Why is the KMCARE registry needed for cancer care data?\",\"answer\":\"Existing cancer registries do not collect integrative medical treatments. KMCARE is established to gather conservative care and Korean medicine data for cancer patients.\"},{\"question\":\"What is the study design and setting for KMCARE?\",\"answer\":\"KMCARE is a prospective observational study based on a registry conducted in five Korean medical hospitals.\"},{\"question\":\"What outcomes are measured during follow-up?\",\"answer\":\"The primary outcome is Functional Assessment of Cancer Therapy-General at 3 months. Secondary outcomes include MD Anderson Symptom Inventory-Core and Body Constitution Questionnaire at 3 and 6 months, with additional safety, survival, and prognostic factor analyses after 6 months.\"}]","A Prospective Multi-Centered Registry-Based Observational Study for Patients With Cancer - Design and Rationale for Korean Medicine Cancer Registry (KMCARE) - Integrative Cancer Therapies Volume 23 | PDF",1790018714,18,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/350b3b95da317a960cf7261cffcec33d.webp",983,1276,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2fd93d9675a45d35140f6a6730e7001.webp",982,1275,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a2aad4a545cd6f3f9a60e6bb8550dc9.webp",981,1273,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/340f12cc2fb999d1e87ad42f580ab151.webp",980,1272]